Multifocal myoclonus as a presentation of levetiracetam toxicity

Background: Levetiracetam (LEV) is widely used for treatment of focal and myoclonic seizures, but reports of LEV toxicity are scarce. Here, we report a rare case of multifocal myoclonus due to LEV toxicity in a patient with chronic renal insufficiency. Case presentation: A 52-year-old woman with his...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mei Bou Nasif, Shweta Varade, Mohamad Z. Koubeissi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/e14dbc7b46d04c72afd11431d863c17d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e14dbc7b46d04c72afd11431d863c17d
record_format dspace
spelling oai:doaj.org-article:e14dbc7b46d04c72afd11431d863c17d2021-11-26T04:37:13ZMultifocal myoclonus as a presentation of levetiracetam toxicity2467-981X10.1016/j.cnp.2021.10.004https://doaj.org/article/e14dbc7b46d04c72afd11431d863c17d2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2467981X21000469https://doaj.org/toc/2467-981XBackground: Levetiracetam (LEV) is widely used for treatment of focal and myoclonic seizures, but reports of LEV toxicity are scarce. Here, we report a rare case of multifocal myoclonus due to LEV toxicity in a patient with chronic renal insufficiency. Case presentation: A 52-year-old woman with history of chronic kidney disease was admitted to the ICU for sedation and intubation after a cardiac arrest. She developed nonconvulsive status epilepticus that resolved after administration of propofol while receiving LEV 1500 mg twice a day. After holding the propofol infusion, the patient started having multifocal myoclonic jerks, documented on video-EEG recordings with a supratherapeutic level of LEV. After discontinuation of LEV, the myoclonus resolved. Conclusion: This is a unique manifestation of LEV toxicity, which has been scarce in the literature. It suggests an inverted U-shaped dose–response of the antimyoclonic effect of LEV.Mei Bou NasifShweta VaradeMohamad Z. KoubeissiElsevierarticleLevetiracetamMultifocal myoclonusPharmacologyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENClinical Neurophysiology Practice, Vol 6, Iss , Pp 281-284 (2021)
institution DOAJ
collection DOAJ
language EN
topic Levetiracetam
Multifocal myoclonus
Pharmacology
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Levetiracetam
Multifocal myoclonus
Pharmacology
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Mei Bou Nasif
Shweta Varade
Mohamad Z. Koubeissi
Multifocal myoclonus as a presentation of levetiracetam toxicity
description Background: Levetiracetam (LEV) is widely used for treatment of focal and myoclonic seizures, but reports of LEV toxicity are scarce. Here, we report a rare case of multifocal myoclonus due to LEV toxicity in a patient with chronic renal insufficiency. Case presentation: A 52-year-old woman with history of chronic kidney disease was admitted to the ICU for sedation and intubation after a cardiac arrest. She developed nonconvulsive status epilepticus that resolved after administration of propofol while receiving LEV 1500 mg twice a day. After holding the propofol infusion, the patient started having multifocal myoclonic jerks, documented on video-EEG recordings with a supratherapeutic level of LEV. After discontinuation of LEV, the myoclonus resolved. Conclusion: This is a unique manifestation of LEV toxicity, which has been scarce in the literature. It suggests an inverted U-shaped dose–response of the antimyoclonic effect of LEV.
format article
author Mei Bou Nasif
Shweta Varade
Mohamad Z. Koubeissi
author_facet Mei Bou Nasif
Shweta Varade
Mohamad Z. Koubeissi
author_sort Mei Bou Nasif
title Multifocal myoclonus as a presentation of levetiracetam toxicity
title_short Multifocal myoclonus as a presentation of levetiracetam toxicity
title_full Multifocal myoclonus as a presentation of levetiracetam toxicity
title_fullStr Multifocal myoclonus as a presentation of levetiracetam toxicity
title_full_unstemmed Multifocal myoclonus as a presentation of levetiracetam toxicity
title_sort multifocal myoclonus as a presentation of levetiracetam toxicity
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e14dbc7b46d04c72afd11431d863c17d
work_keys_str_mv AT meibounasif multifocalmyoclonusasapresentationoflevetiracetamtoxicity
AT shwetavarade multifocalmyoclonusasapresentationoflevetiracetamtoxicity
AT mohamadzkoubeissi multifocalmyoclonusasapresentationoflevetiracetamtoxicity
_version_ 1718409872862609408